🔎 Trials Near Me

Home › HPV › NCT05336240

PCOM2 - The Physician Communication Intervention, Version 2.0

Recruiting

PCOM2 - The Physician Communication Intervention, Version 2.0" for "Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake"

Who can join

Ages 9 to 17 · All sexes

Full eligibility criteria
Inclusion Criteria:

* Parents: Have an adolescent between the ages of 9-17 years old and receiving adolescent care at an enrolled clinic
* Providers: All providers at participating study practices will be eligible to participate.

Exclusion Criteria:

* Parents: Does not have an adolescent between the ages of 9-17 years old and is not receiving adolescent care at an enrolled clinic
* Providers: Providers who are not at participating study practices

About the study

Poor quality of primary care providers' vaccine recommendations lead to low adolescent human papillomavirus vaccination rates and hundreds of thousands of adolescents unnecessarily at risk for HPV-associated cancers and diseases. Though a previous provider communication intervention, called PCOM, was found to be effective for increasing adolescent HPV vaccination in primary care, its dissemination is limited by the need for significant research team involvement to teach providers how to use the intervention's components. To address this, investigators propose to develop and test a virtual version of PCOM, use mixed methods to assess contextual factors affecting its use compared to the original PCOM intervention, and develop an optimized version of PCOM for broad dissemination to increase adolescent HPV vaccination nationally.

What is being tested

Sponsor: University of Colorado, Denver · Participants: 120 · Started: Nov 15, 2023

Contact the study team

Official record on ClinicalTrials.gov — NCT05336240

Locations in the U.S.

ColoradoUniversity of Colorado Anschutz Medical Campus, Aurora
KansasUniversity of Kansas Medical Center, Wichita

Conditions

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.